RNA Analysis Transcriptomics Market to reach over USD 42.4 billion by the year 2031

Global  RNA Analysis Transcriptomics Market is valued at US$ 11.26 Bn in 2023, and it is expected to reach US$ 42.43 Bn by 2031, with a CAGR of 18.30% during the forecast period of 2024-2031.

In the field of biomedical research, the study of RNA through transcriptomics has emerged as a pivotal area driving advancements in understanding genetic expression, disease mechanisms, and personalized medicine. The RNA analysis transcriptomics market is experiencing significant growth, driven in part by its increased utility in predictive biomarkers and RNA therapeutic response research. Increases in biopharmaceutical companies and R&D spending point to a bright future for the global RNA transcriptomics industry.

Download Free Report Sample Pages: https://www.insightaceanalytic.com/request-sample/1403

Recent Developments:

  • In January 2024, Agilent Technologies Inc. announced it would collaborate with Incyte to develop and commercialize its hematology and oncology portfolios. The partnership will leverage Agilent's extensive experience and expertise in companion diagnostics (CDx).
  • In January 2024, Merck, a leading pharmaceutical, biotechnology, and healthcare company, announced a licensing arrangement including the first-in-class oral inhibitor of the creatine transport channel SLC6A8, Ompenaclid (RGX-202), and subsequent medicines that target SLC6A8. The headquarters of Inspirna, Inc. are located in the Big Apple.
  • In January 2024, Promega revealed a new approach to treating hematological cancers, such as multiple myeloma, in a paper published in Nature Communications. The chemical SJ3149 demonstrates potent anti-proliferative effects in various human cancer cell lines by selectively breaking down the cancer-causing protein CK1α.

List of Prominent Players in the RNA Analysis Transcriptomics Market:

  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Pacific Bioscience of California, Inc.
  • Affymetrix, Inc.
  • Danaher
  • Promega

Market Dynamics:

Drivers:

An increase in the need for individualized healthcare, more spending on research and development by pharmaceutical and biotechnology companies, more funding for omics by governments around the world, more widespread use of RNA sequencing, and the creation of novel transcriptomics products by a plethora of influential companies are all factors propelling the global transcriptomics market forward. Transcriptome manufacturing has surged due to high demand in research and development activities and an increased focus on biomarker discovery.

Challenges:

The cost of testing each sample increases due to the high number of laboratory hours required for all processes. It is challenging for developing nations to enter the field of transcriptomics due to the high costs of equipment and chemicals. Worldwide, the adoption of transcriptomic technologies has been lower than anticipated due to the significant expenses required. Anticipated barriers to market growth include a lack of enthusiasm for implementing these technologies. Traditional genomic and transcriptomics tools and methods are expected to threaten the RNA transcriptomics industry.

Regional Trends:

The North America RNA analysis transcriptomics market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the massive investment in transcriptomics research and development, the rising prevalence of increasingly debilitating illnesses such as cancer, and the increasing need for tailored medications. North America dominates the RNA transcriptomics market due to the significant improvements in healthcare in that region.

Segmentation of RNA Analysis Transcriptomics Market-

RNA Analysis Transcriptomics Market- By Product

  • Consumables
  • Instruments
  • Software
  • Services

RNA Analysis Transcriptomics Market- By Technology

  • Microarrays
  • qPCR
  • Sequencing Technology

RNA Analysis Transcriptomics Market- By Application

  • Drug Discovery
  • Diagnostics and Disease Profiling
  • Others

RNA Analysis Transcriptomics Market- By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Order the 180 Pages Detailed Report https://www.insightaceanalytic.com/customisation/1403

Call: North America +1 551 226 6109   Email: diana.dsouza@insightaceanalytics.com

 

Back to news